Caricamento...
A case of remarkable response to atezolizumab in ALK-translocated metastatic lung adenocarcinoma
The development of resistance to tyrosine kinase inhibitors (TKIs) in metastatic non-small cell lung cancer (NSCLC) with oncogenic driver mutations highlights the challenge in improving the survival of these patients. The standard of care for ALK-rearranged advanced NSCLC refractory to various gener...
Salvato in:
| Pubblicato in: | Respir Med Case Rep |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8318922/ https://ncbi.nlm.nih.gov/pubmed/34336591 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2021.101478 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|